Particle-Induced Pulmonary Acute Phase Response Correlates with Neutrophil Influx Linking Inhaled Particles and Cardiovascular Risk

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Saber, Anne Thoustrup ^a   Lamson, Jacob Stuart ^a   Jacobsen, Nicklas Raun ^a   Ravn Haren, Gitte ^b   Hougaard, Karin Sørig ^a   Nyendi, Allen Njimeri ^a   Wahlberg, Pia ^c   Madsen, Anne Mette ^a   Jackson, Petra ^a   Wallin, Håkan ^a,d   Vogel, Ulla ^a,b  

^a NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^c DANISH TECHNOLOGICAL INSTITUTE   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON BLACK; HIGH DENSITY LIPOPROTEIN; MESSENGER RNA; MULTI WALLED NANOTUBE; NANOMATERIAL; SERUM AMYLOID A; SINGLE WALLED NANOTUBE; TITANIUM DIOXIDE; UNCLASSIFIED DRUG;

ACUTE PHASE RESPONSE; AIRBORNE PARTICLE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATIONAL STUDY; DUST; EXHAUST GAS; FEMALE; GENE EXPRESSION; INHALATION; LUNG LAVAGE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; RISK FACTOR; SAA3 GENE; TISSUE LEVEL;

EID: 84880828549     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069020     Document Type: Article

References (66)

1. Pope CA III, Burnett RT, Thurston GD, Thun MJ, Calle EE, et al. (2004) Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation 109: 71-77.
2. Fang SC, Cassidy A, Christiani DC, (2010) A Systematic Review of Occupational Exposure to Particulate Matter and Cardiovascular Disease. International Journal of Environmental Research and Public Health 7: 1773-1806.
3. Oberdorster G, Oberdorster E, Oberdorster J, (2005) Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113: 823-839.
4. Taubes G, (2002) Cardiovascular disease. Does inflammation cut to the heart of the matter? Science 296: 242-245.
5. Packard RR, Libby P, (2008) Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem 54: 24-38.
6. Gabay C, Kushner I, (1999) Mechanisms of disease: Acute-phase proteins and other systemic responses to inflammation. New England Journal of Medicine 340: 448-454.
7. Lowe GD, (2001) The relationship between infection, inflammation, and cardiovascular disease: an overview. Ann Periodontol 6: 1-8.
8. Mezaki T, Matsubara T, Hori T, Higuchi K, Nakamura A, et al. (2003) Plasma levels of soluble thrombomodulin, C-reactive protein, and serum amyloid A protein in the atherosclerotic coronary circulation. Jpn Heart J 44: 601-612.
9. Libby P, Okamoto Y, Rocha VZ, Folco E, (2010) Inflammation in atherosclerosis: transition from theory to practice. Circ J 74: 213-220.
10. Pussinen PJ, Tuomisto K, Jousilahti P, Havulinna AS, Sundvall J, et al. (2007) Endotoxemia, immune response to periodontal pathogens, and systemic inflammation associate with incident cardiovascular disease events. Arteriosclerosis Thrombosis and Vascular Biology 27: 1433-1439.
11. Estabragh ZR, Mamas MA (2013) The cardiovascular manifestations of influenza: A systematic review. Int J Cardiol.
12. Ridker PM, Hennekens CH, Buring JE, Rifai N, (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342: 836-843.
13. Hertel S, Viehmann A, Moebus S, Mann K, Brocker-Preuss M, et al. (2010) Influence of short-term exposure to ultrafine and fine particles on systemic inflammation. European Journal of Epidemiology 25: 581-592.
14. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, et al. (2004) Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 351: 2599-2610.
15. Uhlar CM, Whitehead AS, (1999) Serum amyloid A, the major vertebrate acute-phase reactant. European Journal of Biochemistry 265: 501-523.
16. Chiba T, Han CY, Vaisar T, Shimokado K, Kargi A, et al. (2009) Serum amyloid A3 does not contribute to circulating SAA levels. Journal of Lipid Research 50: 1353-1362.
17. Meek RL, Urielishoval S, Benditt EP, (1994) Expression of Apolipoprotein Serum Amyloid-A Messenger-Rna in Human Atherosclerotic Lesions and Cultured Vascular Cells- Implications for Serum Amyloid-A Function. Proceedings of the National Academy of Sciences of the United States of America 91: 3186-3190.
18. Whitehead AS, Zahedi K, Rits M, Mortensen RF, Lelias JM, (1990) Mouse C-reactive protein. Generation of cDNA clones, structural analysis, and induction of mRNA during inflammation. Biochem J 266: 283-290.
19. Halappanavar S, Jackson P, Williams A, Jensen KA, Hougaard KS, et al. (2011) Pulmonary response to surface-coated nanotitanium dioxide particles includes induction of acute phase response genes, inflammatory cascades, and changes in microRNAs: A toxicogenomic study. Environ Mol Mutagen 52: 425-439.
20. Saber AT, Jacobsen NR, Mortensen A, Szarek J, Jackson P, et al. (2012) Nanotitanium dioxide toxicity in mouse lung is reduced in sanding dust from paint. Part Fibre Toxicol 9: 4.
21. Bourdon JA, Saber AT, Jacobsen NR, Jensen KA, Madsen AM, et al. (2012) Carbon black nanoparticle instillation induces sustained inflammation and genotoxicity in mouse lung and liver. Part Fibre Toxicol 9: 5.
22. Jackson P, Hougaard KS, Boisen AM, Jacobsen NR, Jensen KA, et al. (2012) Pulmonary exposure to carbon black by inhalation or instillation in pregnant mice: effects on liver DNA strand breaks in dams and offspring. Nanotoxicology 6: 486-500.
23. Hougaard KS, Jackson P, Jensen KA, Sloth JJ, Loschner K, et al. (2010) Effects of prenatal exposure to surface-coated nanosized titanium dioxide (UV-Titan). A study in mice. Part Fibre Toxicol 7: 16.
24. Saber AT, Halappanavar S, Folkmann JK, Bornholdt J, Boisen AM, et al. (2009) Lack of acute phase response in the livers of mice exposed to diesel exhaust particles or carbon black by inhalation. Part Fibre Toxicol 6: 12.
25. Bourdon JA, Halappanavar S, Saber AT, Jacobsen NR, Williams A, et al. (2012) Hepatic and pulmonary toxicogenomic profiles in mice intratracheally instilled with carbon black nanoparticles reveal pulmonary inflammation, acute phase response, and alterations in lipid homeostasis. Toxicol Sci 127: 474-484.
26. Husain M, Saber AT, Guo C, Jacobsen NR, Jensen KA, et al. (2013) Pulmonary instillation of low doses of titanium dioxide nanoparticles in mice leads to particle retention and gene expression changes in the absence of inflammation. Toxicol Appl Pharmacol 269: 250-262.
27. Li Z, Hulderman T, Salmen R, Chapman R, Leonard SS, et al. (2007) Cardiovascular effects of pulmonary exposure to single-wall carbon nanotubes. Environmental Health Perspectives 115: 377-382.
28. Chen LC, Nadziejko C, (2005) Effects of subchronic exposures to concentrated ambient particles (CAPs) in mice: V. CAPs exacerbate aortic plaque development in hyperlipidemic mice. Inhalation Toxicology 17: 217-224.
29. Mikkelsen L, Sheykhzade M, Jensen KA, Saber AT, Jacobsen NR, et al. (2011) Modest effect on plaque progression and vasodilatory function in atherosclerosis-prone mice exposed to nanosized TiO2. Part Fibre Toxicol 8: 32.
30. Wang X, Chai H, Wang Z, Lin PH, Yao Q, et al. (2008) Serum amyloid A induces endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells. Am J Physiol Heart Circ Physiol 295: H2399-H2408.
31. Madsen AM, Saber AT, Nordly P, Sharma AK, Wallin H, et al. (2008) Inflammation but no DNA (deoxyribonucleic acid) damage in mice exposed to airborne dust from a biofuel plant. Scand J Work Environ Health 34: 278-7.
32. Saber AT, Bornholdt J, Dybdahl M, Sharma AK, Loft S, et al. (2005) Tumor necrosis factor is not required for particle-induced genotoxicity and pulmonary inflammation. Arch Toxicol 79: 177-182.
33. Saber AT, Jensen KA, Jacobsen NR, Birkedal R, Mikkelsen L, et al. (2012) Inflammatory and genotoxic effects of nanoparticles designed for inclusion in paints and lacquers. Nanotoxicology 6: 453-471.
34. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
35. Terpstra AH, Woodward CJ, Sanchez-Muniz FJ, (1981) Improved techniques for the separation of serum lipoproteins by density gradient ultracentrifugation: visualization by prestaining and rapid separation of serum lipoproteins from small volumes of serum. Anal Biochem 111: 149-157.
36. Feingold KR, Grunfeld C, (2010) The acute phase response inhibits reverse cholesterol transport. Journal of Lipid Research 51: 682-684.
37. Badolato R, Wang JM, Murphy WJ, Lloyd AR, Michiel DF, et al. (1994) Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med 180: 203-209.
38. Jackson P, Hougaard KS, Vogel U, Wu D, Casavant L, et al. (2012) Exposure of pregnant mice to carbon black by intratracheal instillation: toxicogenomic effects in dams and offspring. Mutat Res 745: 73-83.
39. Teeguarden JG, Webb-Robertson BJ, Waters KM, Murray AR, Kisin ER, et al. (2011) Comparative proteomics and pulmonary toxicity of instilled single-walled carbon nanotubes, crocidolite asbestos, and ultrafine carbon black in mice. Toxicol Sci 120: 123-135.
40. Chang CC, Chen SH, Ho SH, Yang CY, Wang HD, et al. (2007) Proteomic analysis of proteins from bronchoalveolar lavage fluid reveals the action mechanism of ultrafine carbon black-induced lung injury in mice. Proteomics 7: 4388-4397.
41. Kaptoge S, Di AE, Pennells L, Wood AM, White IR, et al. (2012) C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 367: 1310-1320.
42. Stulnig TM, (2013) C-reactive protein, fibrinogen, and cardiovascular risk. N Engl J Med 368: 84-85.
43. Elliott P, Chambers JC, Zhang W, Clarke R, Hopewell JC, et al. (2009) Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 302: 37-48.
44. Vogel U, Jensen MK, Due KM, Rimm EB, Wallin H, et al. (2011) The NFKB1 ATTG ins/del polymorphism and risk of coronary heart disease in three independent populations. Atherosclerosis 219: 200-204.
45. Vogel U (in press) Commentary. Atherosclerosis.
46. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, et al. (2000) Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 321: 199-204.
47. Dong Z, Wu T, Qin W, An C, Wang Z, et al. (2011) Serum Amyloid A Directly Accelerates the Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice. Mol Med.
48. King VL, Thompson J, Tannock LR, (2011) Serum amyloid A in atherosclerosis. Curr Opin Lipidol 22: 302-307.
49. Gitlin JM, Loftin CD, (2009) Cyclooxygenase-2 inhibition increases lipopolysaccharide-induced atherosclerosis in mice. Cardiovascular Research 81: 400-407.
50. Lalla E, Lamster IB, Hofmann MA, Bucciarelli L, Jerud AP, et al. (2003) Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice. Arteriosclerosis Thrombosis and Vascular Biology 23: 1405-1411.
51. Li L, Messas E, Batista EL, Levine RA, Amar S, (2002) Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation 105: 861-867.
52. Annema W, Nijstad N, Tolle M, de Boer JF, Buijs RVC, et al. (2010) Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A(2). Journal of Lipid Research 51: 743-754.
53. Jahangiri A, de Beer MC, Noffsinger V, Tannock LR, Ramaiah C, et al. (2009) HDL remodeling during the acute phase response. Arterioscler Thromb Vasc Biol 29: 261-267.
54. Duffin R, Tran L, Brown D, Stone V, Donaldson K, (2007) Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: highlighting the role of particle surface area and surface reactivity. Inhal Toxicol 19: 849-856.
55. Bai N, Kido T, Suzuki H, Yang G, Kavanagh TJ, Kaufman JD, Rosenfeld ME, van BC, Eeden SF (2011) Changes in atherosclerotic plaques induced by inhalation of diesel exhaust. Atherosclerosis.
56. RL, Eriksen N, Benditt EP, (1992) Murine serum amyloid A3 is a high density apolipoprotein and is secreted by macrophages. Proc Natl Acad Sci U S A 89: 7949-7952.
57. A, Wuyts A, Proost P, Struyf S, Opdenakker G, van DJ, (1996) Leukocyte migration and activation by murine chemokines. Immunobiology 195: 499-521.
58. Pope CA III, Hansen ML, Long RW, Nielsen KR, Eatough NL, Wilson WE, Eatough DJ, (2004) Ambient particulate air pollution, heart rate variability, and blood markers of inflammation in a panel of elderly subjects. Environ Health Perspect 112: 339-345.
59. Riediker M, Cascio WE, Griggs TR, Herbst MC, Bromberg PA, Neas L, Williams RW, Devlin RB, (2004) Particulate matter exposure in cars is associated with cardiovascular effects in healthy young men. Am J Respir Crit Care Med 169: 934-940.
60. Peters A, Frohlich M, Doring A, Immervoll T, Wichmann HE, Hutchinson WL, Pepys MB, Koenig W, (2001) Particulate air pollution is associated with an acute phase response in men; results from the MONICA-Augsburg Study. Eur Heart J 22: 1198-1204.
61. Delfino RJ, Staimer N, Tjoa T, Polidori A, Arhami M, Gillen DL, Kleinman MT, Vaziri ND, Longhurst J, Zaldivar F, Sioutas C, (2008) Circulating biomarkers of inflammation, antioxidant activity, and platelet activation are associated with primary combustion aerosols in subjects with coronary artery disease. Environ Health Perspect 116: 898-906.
62. Huttunen K, Siponen T, Salonen I, Yli-Tuomi T, Aurela M, Dufva H, Hillamo R, Linkola E, Pekkanen J, Pennanen A, Peters A, Salonen RO, Schneider A, Tiittanen P, Hirvonen MR, Lanki T, (2012) Low-level exposure to ambient particulate matter is associated with systemic inflammation in ischemic heart disease patients. Environ Res 116: 44-51.
63. Barregard L, Sallsten G, Gustafson P, Andersson L, Johansson L, Basu S, Stigendal L, (2006) Experimental exposure to wood-smoke particles in healthy humans: effects on markers of inflammation, coagulation, and lipid peroxidation. Inhal Toxicol 18: 845-853.
64. Danesh J, Muir J, Wong YK, Ward M, Gallimore JR, Pepys MB, (1999) Risk factors for coronary heart disease and acute-phase proteins. A population-based study. Eur Heart J 20: 954-959.
65. Balci B, (2011) The modification of serum lipids after acute coronary syndrome and importance in clinical practice. Curr Cardiol Rev 7: 272-276.
66. Pfohl M, Schreiber I, Liebich HM, Haring HU, Hoffmeister HM, (1999) Upregulation of cholesterol synthesis after acute myocardial infarction-is cholesterol a positive acute phase reactant? Atherosclerosis 142: 389-393.